Research Summary
Dr. Demidowich is very interested in the interplay between inflammation and metabolic health. To this end, he has obtained several NIH grants to study colchicine's effects on obesity and metabolic syndrome. His studies have demonstrated that colchicine suppresses obesity-induced inflammation, reduces insulin resistance, and may improves certain vascular-related markers.
Additionally, Dr. Demidowich is passionate about examining and improving the delivery of care to patients with diabetes in the inpatient setting. He has published extensively on this topic and has several ongoing studies.
Selected Publications
View all on PubMed
Demidowich AP, Batty K, Zilbermint M. Instituting a Successful Discharge Plan for Patients with Type 2 Diabetes: Challenges and Solutions. Diabetes Spectrum. 2022 Fall;35(4):440-451. doi: 10.2337/dsi22-0013
Demidowich AP, Batty K, Love T, Sokolinsky S, Grubb L, Miller C, Raymond L, Nazarian J, Ahmed MS, Rotello L, Zilbermint M. Effects of a Dedicated Inpatient Diabetes Management Service on Glycemic Control in a Community Hospital Setting. J Diabetes Sci Technol. 2021 Feb 20. doi: 10.1177/1932296821993198
Hannah-Shmouni F, Demidowich A, Stratakis C. Cortisol in the Evaluation of Adrenal Insufficiency. JAMA. 2016;316(5):535.
Demidowich AP, Davis AI, Dedhia N, Yanovski JA. Colchicine to decrease NLRP3-activated inflammation and improve obesity-related metabolic dysregulation. Medical Hypotheses. 2016 Jul;92:67-73.
Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, Freeman AF, Demidowich A, Davis J, Turner ML, Anderson VL, Darnell DN, Welch PA, Kuhns DB, Frucht DM, Malech HL, Gallin JI, Kobayashi SD, Whitney AR, Voyich JM, Musser JM, Woellner C, Schäffer AA, Puck JM, Grimbacher B. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med. 2007 Oct 18; 357(16):1608-19.
Patient Ratings & Comments
The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.